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Abstract 
Purpose: Surface irregularities of the greater trochanter have been described as a 
potential radiographic sign of greater trochanteric pain syndrome (GTPS). We report 
a diagnostic accuracy study to evaluate the clinical usefulness of trochanteric 
surface irregularities on plain radiographs in the diagnosis of GTPS. 
Methods: We retrospectively identified the AP pelvic radiographs of a consecutive 
group of 38 patients (representing a 27.5% series prevalence) diagnosed with GTPS 
(mean age 69.5 years ± 16.1 [standard deviation], 27 females, 11 males) based on 
clinical symptoms and a positive response to a local anaesthetic and steroid 
injection. A control group consisted of 100 patients (mean age 73 years ± 17.1 
[standard deviation], 67 females, 33 males) with either hip osteoarthritis listed for hip 
arthroplasty (n=50), or with an intracapsular neck of femur fracture (n=50) both 
presenting between January and July 2017. Radiographs were cropped to blind 
observers to the presence of hip osteoarthritis or intracapsular fracture but include 
the trochanteric region. The radiograph sequence was randomized and separately 
presented to three orthopaedic surgeons to evaluate the presence of trochanteric 
surface irregularities.  
Results: The inter-observer correlation coefficient agreement was acceptable at 0.75 
(95% CI: 0.60-0.84). Trochanteric surface irregularities including frank spurs 
protruding ≥2 mm were associated with a 24.7% positive predictive value, 64.0% 
sensitivity, 25.7% specificity, 74.3% false-positive rate, 36.0% false-negative rate, 
and a 65.3% negative predictive value for clinical GTPS. 
Conclusion: Surface irregularities of the greater trochanter are not reliable 
radiographic indicators for the diagnosis of greater trochanteric pain syndrome. 
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Introduction 
Greater trochanteric pain syndrome (GTPS) is a poorly understood condition of the 
hip, characterised by disabling pain over the lateral aspect of the greater trochanter 
(1). Although it is still sometimes referred to as ‘trochanteric bursitis’, it is now also 
understood to be caused by tendinopathy or macroscopic tearing of the gluteus 
medius or minimus tendons. GTPS has a prevalence of approximately 18% in the 
general population (2), mainly affecting those between the ages of 40-60 years with 
a 4:1 female preponderance (3,4).  
 
Diagnosis is made by history and clinical examination, however radiographs of the 
pelvis are routinely performed to exclude differential diagnoses such as degenerative 
hip joint disease, trochanteric avulsion fracture and periosteal neoplastic lesions or 
secondary malignancy of the proximal femur (5).  
 
Irregularities of the surface of the greater trochanter have been described as a 
radiographic sign of GTPS (1,4). Surface irregularities include tendinous calcification, 
exostoses or enthesophytes of the greater trochanter, which may result from 
abductor tendinopathy or bursal inflammation (6,7). Steinert et al. found that 90% of 
hips with trochanteric enthesophytes protruding ≥2 mm from the cortical surface 
were associated with abductor tendon abnormalities and peritendinous edema on 
magnetic resonance imaging (8). It is unclear however, whether these surface 
irregularities of the greater trochanter are of any clinical significance. We report a 
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diagnostic accuracy study to evaluate whether surface irregularities of the greater 
trochanter on plain radiographs have any clinical utility in the diagnosis of GTPS. 
 
Materials and Methods 
Patient selection 
We retrospectively identified the radiographs of a consecutive series of patients 
listed for surgical treatment of GTPS. These patients had all responded successfully, 
albeit temporarily, to an injection of local anaesthetic and steroid infiltrated around 
the trochanteric bursa region. Patients were included if an anteroposterior (AP) 
pelvic radiograph was available from the time of diagnosis of GTPS and fulfilled our 
radiograph selection criteria, as detailed below. These 56 patients have been 
reported in a previous study (9) that evaluated patient reported outcomes following 
trochanteric bursectomy and transposition of the gluteal fascia. The patients in this 
previous study were diagnosed with GTPS based on clinical history and greater 
trochanteric tenderness. They all underwent surgery when symptoms had persisted 
for over twelve months and a transient response to conservative measures, including 
corticosteroid injection and physiotherapy was observed. 
 
For comparison, we used AP pelvic radiographs from 2 control groups both treated 
at our institution between January and July 2017. The first control group consisted of 
a consecutive series of patients with hip osteoarthritis listed for primary total hip 
replacement. The osteoarthritis group included patients of a similar age to the GTPS 
group (68.0 vs 69.5 years); as it is a possibility that osteoarthritis may overlap with 
GTPS, we included a second control group.  The second control group were patients 
admitted with an intracapsular hip fracture. The clinical records for both control 
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groups were accessed through our institution’s electronic database, BlueSpier 
(Bluespier, Droitwich, Worcester, UK). The clinical notes were reviewed to exclude 
patients reporting clinical features suggestive of GTPS. 
 
Radiograph selection 
Radiographs and radiological reports were accessed from our Picture Archiving 
Communication Service (PACS). All pelvic radiographs were standardised in the AP 
orientation. Where possible, patients were supine with internal rotation of the legs to 
20°. The beam was not angled. All radiographs were anonymised and to blind 
observers to the underlying diagnosis, a standardised high-resolution section of each 
radiograph was cropped for radiographic interpretation by the observers. These 
sections permitted sufficient visualisation of the superior and lateral borders of the 
greater trochanter only, corresponding to the insertion points of the gluteus medius, 
minimus and vastus lateralis tendons. Patients were excluded if radiographs were 
not taken in a standardised AP orientation, if laterality was uncertain and if the 
standardised section of radiograph contained any evidence of the underlying 
diagnosis. Furthermore, patients in the control group were excluded if they 
underwent primary hip arthroplasty for an indication other than osteoarthritis. 
 
Randomisation 
We identified 50 patients with osteoarthritis, 50 patients with an intracapsular neck of 
femur fracture and 38 patients with GTPS, that met the eligibility criteria (see Figure 
I). Demographic information for the study group is displayed in Table I. Cropped 
radiographs for each patient were transferred to separate slides of a PowerPoint 
presentation (Microsoft®). Each slide was designated an arbitrary rank and a 
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random number generator (RANDOM.ORG; Dublin, IR) was used to randomly re-
sequence the order of the radiographs throughout the PowerPoint presentation. 
 
Analysis and statistical methods 
Radiographs were presented sequentially and independently to three orthopaedic 
surgeons with subspecialist interest in the treatment of disorders of the hip. Due to 
the randomisation process, neither surgeon or researcher knew which group the 
patient belonged to during analysis. For each radiograph, observers were asked to 
assign each hip into one of three categories, similar to the methods of Steinert et al. 
(2010). Radiographs were described as ‘normal’ in the absence of trochanteric 
irregularities; ‘small’ indicated subtle cortical irregularities or enthesophytes 
protruding <2 mm from the cortical surface; ‘large’ indicated enthesophytes 
protruding ≥2 mm, see Figure II. All observers were blinded to the underlying 
pathology of each hip and the prevalence of GTPS within the series.  
Given the different diagnostic ‘cut-offs’ the area under the receiver operating 
characteristic curve was determined. Statistical analysis was performed by Excel and 
IBM SPSS Statistics for Windows v22.0 (IBM Corp; Armonk, NY). 
 
Results 
Inter-observer agreement 
A two-way mixed model intra-class correlation coefficient between the three 
observers was calculated to determine inter-observer agreement. The inter-observer 
correlation coefficient for three grades of trochanteric abnormality (normal, small 
surface irregularity or a frank spur ≥2 mm) was 0.75 (95% CI 0.60-0.84). This value 
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represents acceptable internal consistency of observations among the three 
observers.  
 
Normal versus small or large enthesophytes 
A total of 138 radiographs were included for assessment by the three observers. The 
prevalence of patients with clinical GTPS in this series was 27.5%. Overall, the 
positive predictive value of trochanteric surface irregularities or enthesophytes 
protruding ≥2 mm seen on plain radiographs was poor (24.7%) for clinical GTPS. 
Furthermore, such abnormalities were associated with a 64.0% sensitivity, 25.7% 
specificity, 74.3% false positive rate, a 36.0% false negative rate, and a 65.3% 
negative predictive value for clinical GTPS.  
 
The diagnostic accuracy of detecting GTPS varied between observers, when 
comparing normal cortical surfaces of the greater trochanter to those with both 
‘small’ and ‘large’ cortical irregularities, see Table II. Positive likelihood ratios were 
0.83 for Observer 1, 0.82 for Observer 2 and 0.91 for Observer 3. Negative likelihood 
ratios were 1.40, 1.25 and 2.64 for each observer, respectively. 
 
Normal or small vs large enthesophytes 
The mean number of large enthesophytes recorded for each group was 7 (range 6-
8) in the GTPS group, 10 (range 9-13) in the osteoarthritis group and 8 (range 3-17) 
in the hip fracture group. Refining the diagnostic criteria to include only large 
enthesophytes did not improve the diagnostic accuracy, see Table III.  
 
Diagnostic Test Receiver Operating Characteristics 
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The area under the curve for the presence of cortical irregularities and frank spurs 
was 0.45 (95% CI 0.39-.52). 
 
Discussion 
Our results indicate that surface irregularities of the greater trochanter on plain 
radiographs are not reliable radiological indicators for the diagnosis of GTPS.  
 
‘Degenerative enthesopathy’ is a term coined by Resnick and Niwayama (1983) to 
describe the enthesophytes that develop at tendinous insertions into bone. Such 
spurs may be associated with aging and factors such as microtrauma, muscular 
activity and local ischaemia (10). Steinert et al. reported that spurs ≥2 mm were 
associated with peritendinous edema at the insertions of gluteus medius and 
minimus on magnetic resonance imaging. In the series by Steinert et al., spurs were 
found to be 96-98% specific but only 18-28% sensitive, for edematous tendon 
abnormalities (8). It is noteworthy that peritendinous edema is not specific for bursal 
inflammation or symptomatic hip pain. Blakenbaker et al. report that 88% of 240 
patients without trochanteric pain had peritrochanteric abnormalities (11). Thus, large 
spurs, although associated with peritrochanteric edema, may not be associated with 
clinically symptomatic GTPS. 
 
Our study blinded observers to the underlying diagnosis and the prevalence of the 
target condition in the series. The observed radiographic images were carefully 
cropped in a standardised manner followed by randomisation of the order in which 
they were presented to observers to preserve blinding. Inter-observer agreement 
was acceptable, suggesting that cortical irregularities are reliably identifiable on 
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radiographs. We acknowledge small inherent age differences between the case and 
control groups. Accordingly, a greater prevalence of enthesopathy among the older 
hip fracture group was observed. In addition, minor changes in leg rotation at the 
time of performing the radiograph may rotate surface irregularities out of view. 
Controlling rotation following hip fracture is particularly difficult due to discomfort, and 
likewise internal rotation is usually restricted in patients with hip arthritis. Excessive 
external rotation within both arms of the control group may rotate trochanteric 
surface irregularities out of view. This would however serve to reduce any observed 
trochanteric abnormalities in the control group and artificially increase any 
association in the GTPS group. Our diagnostic accuracy data therefore represents a 
best-case scenario; it is possible that trochanteric abnormalities may be of even less 
use for diagnosing GTPS than we report. 
 
Contrary to previous work, we conclude that cortical irregularities of the greater 
trochanter, including frank spurs, have no clinical utility in the diagnosis of the 
greater trochanteric pain syndrome. 
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Table I: Demographic details for each group 
 
GTPS = greater trochanteric pain syndrome.  
 
  
Group Number 
of hips 
Mean age 
(± SD) 
Number of 
males (%) 
Number of 
females (%) 
Laterality 
(Rt vs Lt) 
GTPS 38 69.5 (±16.1) 11 (29) 27 (71) 22 vs. 16 
Osteoarthritis 50 68.0 (±12.9) 16 (32) 34 (68) 24 vs. 26 
Hip fracture 50 78.6 (±19.3) 17 (34) 33 (66) 23 vs. 27 
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Table II: Diagnostic values for the detection of GTPS using any 
radiographic abnormality (small surface irregularities and spurs ≥2 mm). 
 
 
 
  
 
Observer 
Positive 
predictive 
value (%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
False-
positive 
rate (%) 
False-
negative 
rate (%) 
Negative 
predictive 
value (%) 
Observer 1 23.9 57.9 30.0 70.0 42.1 65.2 
Observer 2 23.7 47.4 42.0 58.0 52.6 67.7 
Observer 3 25.8 86.8 5.0 95.0 13.2 50.0 
Overall 24.7 64.0 25.7 74.3 36.0 65.3 
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Table III: Diagnostic values for the detection of GTPS using only large spurs 
≥2mm as the diagnostic criteria.  
 
  
Observer Positive 
predictive 
value (%) 
Sensitivity 
(%) 
Specificity 
(%) 
False-
positive 
rate (%) 
False-
negative 
rate (%) 
Negative 
predictive 
value (%) 
Observer 1 36.4 21.1 86.0 14.0 78.9 74.1 
Observer 2 25.0 15.8 82.0 18.0 84.2 71.9 
Observer 3 21.1 21.1 70.0 30.0 78.9 70.0 
Overall 26.2 19.3 79.3 20.7 80.7 72.1 
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Figure Captions 
 
Figure I: Flowchart of patient selection. Other exclusion criteria in the control group 
included patients that underwent primary hip arthroplasty for an indication other than 
osteoarthritis, including hypochondroplasia, avascular necrosis and rheumatoid 
arthritis. Other exclusion criteria in the GTPS group included a case of avascular 
necrosis and peri-prosthetic fracture. GTPS = greater trochanteric pain syndrome; 
THR = total hip replacement; NOF = neck of femur. 
 
 
Figure II: Standardised AP plain radiograph sections of the right greater trochanter. 
A) normal cortical surface in a 77-year-old male with GTPS. B) subtle cortical 
irregularities (arrows) in an 88-year-old male with an intracapsular neck of femur 
fracture; C) large superolateral enthesophyte (arrows) in an 84-year-old female with 
GTPS. 
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